Preprint Article Version 1 This version is not peer-reviewed

Predication of Low-Grade Placental Inflammation in Obesity and Gestational Diabetes Mellitus

Version 1 : Received: 6 September 2024 / Approved: 9 September 2024 / Online: 9 September 2024 (14:04:26 CEST)

How to cite: Kolcsar, B.; Kemény, K. K.; Kozinszky, Z.; Ducza, E.; Suranyi, A. Predication of Low-Grade Placental Inflammation in Obesity and Gestational Diabetes Mellitus. Preprints 2024, 2024090675. https://doi.org/10.20944/preprints202409.0675.v1 Kolcsar, B.; Kemény, K. K.; Kozinszky, Z.; Ducza, E.; Suranyi, A. Predication of Low-Grade Placental Inflammation in Obesity and Gestational Diabetes Mellitus. Preprints 2024, 2024090675. https://doi.org/10.20944/preprints202409.0675.v1

Abstract

Maternal obesity and gestational diabetes mellitus (GDM) are the most common metabolic conditions with have unfavourable impact on maternal and fetal health. Key biosubtrats such as apelin, vascular endothelial growth factor (VEGF), leptin, and DNA methylation play crucial roles in these pathologic conditions. Apelin is a peptide involved in regulating glucose metabolism and cardiovascular functions. This molecule also interacts with the apelin receptor to enhance glucose uptake, suggesting potential therapeutic implications for managing GDM and obesity. Leptin, a hormone predominantly produced by adipose tissue, regulates appetite and energy balance. In obesity, leptin levels are often high, but a resistance to its effects develops, disrupting normal metabolic processes. Similarly, in GDM, elevated leptin may impair glucose metabolism and contribute to insulin resistance. VEGF is critical for angiogenesis, the formation of new blood vessels, and is often found in increased concentrations in obese individuals and those with GDM. This elevation may contribute to abnormal placental function and vascular complications, exacerbating both conditions. DNA methylation, an epigenetic modification, plays a crucial role in gene expression regulation. In both GDM and obesity, altered DNA methylation patterns have been observed, affecting genes involved in metabolism, inflammation, and insulin sensitivity. These epigenetic changes may predispose individuals to metabolic disorders. In our study we investigated placental apelin, leptin, VEGF, and DNA methylation interconnection in the pathophysiology of GDM and obesity during gestation. They have similar or different influencing on metabolic regulation, vascular function, and gene expression in GDM and obesity? Sonogpahic examinatios supported the metabolic analyses for that understanding their roles may lead to better management and therapeutic strategies for these conditions.

Keywords

apelin; leptin; VEGF; DNA methylation; human pregnancy; obesity; placenta; diabetes

Subject

Medicine and Pharmacology, Pathology and Pathobiology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.